ArticleJoint diseases and related surgery2025
Effect of posterior-stabilized and cruciate-retaining implants on three-dimensional kinematic characteristics after total knee arthroplasty.
Article in Joint diseases and related surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to analyze the effects of posteriorstabilized (PS) and cruciate-retaining (CR) total knee arthroplasty (TKA) on early postoperative three-dimensional (3D) dynamic and kinematic characteristics in patients with unilateral knee osteoarthritis (OA). PATIENTS AND
methodsA retrospective analysis of prospectively collected data from 90 patients with unilateral TKA between February 2021 and September 2021 was conducted using a 3D kinematic analysis system before and six months after TKA. This patient group included 57 patients (10 males, 47 females; mean age: 69.5±7.5 years; range, 53 to 85 years) who underwent PS TKA and 33 patients (11 males, 22 females; mean age: 67.9±8.8 years; range, 45 to 86 years) who underwent CR TKA. The kinematic characteristics and clinical results of the two groups were compared. Clinical evaluation included the Hospital for Special Surgery knee score and range of motion (ROM). Twenty-eight healthy controls (9 males, 19 females; mean age: 64.5±2.9 years; range, 61 to 75 years) without knee OA matched for age, weight, height, and body mass index were recruited. The kinematic characteristics of the healthy control group were also evaluated.
resultsThe PS group exhibited significant changes in basic gait parameters after TKA, including cadence (p=0.046), stride time (p=0.011), opposite foot off (p<0.001), opposite foot contact (p=0.038), step time (p=0.005), double support period (p<0.001), and foot off (p=0.004). No significant differences were observed in the kinematic parameters before and after TKA between the PS and CR groups, such as knee angle, moment, and force. The dynamic ROM of the CR group was greater than that of the PS group (p<0.001). Both the PS and CR groups showed significant deficiencies in flexion and extension function, including knee flexion moment, extension force, maximum flexion angle, and dynamic ROM, compared to healthy individuals. Throughout the gait cycle, both the PS and CR groups showed better knee joint stability compared to healthy individuals.
conclusionAt six months postoperatively, both the PS and CR groups' gait patterns did not recover to a healthy state, and the CR group's gait pattern was more similar to OA. Compared to PS TKA, CR TKA allowed for greater dynamic ROM during gait. Despite exhibiting superior knee stability during gait, both implants' knee kinematics function remained inferior compared to healthy individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.